South & Central America Bioreactors Market Forecast to 2030 - Regional Analysis - by Scale (Lab-Scale Production, Pilot-Scale Production, and Full-Scale Production), Application (Microbial Application, Cell Culture Application, and Others), Technology (Fed-Batch Bioreactors and Perfusion Bioreactors), and End User (Biopharma Manufacturers, Research and Development Organizations, and Contract Manufacturing Organization)

BMIRE00030246 | Pages: 74 | Biotechnology | Jun 2024 | Type: Regional | Status: Published

The South & Central America bioreactors market was valued at US$ 246.23 million in 2022 and is expected to reach US$ 388.31 million by 2030; it is estimated to grow at a CAGR of 5.9% from 2022 to 2030.

Rapid Growth of Pharmaceutical and Biotechnology Industry Fuels South & Central America Bioreactors Market

In recent years, the pharmaceutical industry has been growing at an unprecedented pace. Big pharmaceutical companies and contract research organizations (CROs) are coming up with new medicines and therapy forms to treat a wide range of indications. The biopharmaceuticals market is increasing. The strong demand for biologics and biosimilars has driven the growth of the industry. The biopharmaceutical industry is one of the most significant contributors to the economy. With 105 events approved, Brazil is the world's second-largest producer of biotech crops. According to FAS Brasilia, 68 million hectares will be planted with GE traits during the 2022–2023 agricultural season. Besides growing economies, rapid growth is witnessed in the research environment in emerging economies such as Brazil, China, and India. Factors such as increasing biologics approval, growing biosimilar pipeline, and rising investment in research activities are facilitating the growth of the industry.

Biopharmaceutical research activities are gaining pace in emerging economies such as Brazil, China, and India and offering lucrative opportunities to the market. Apart from this, increasing approvals in gene and cell therapies are favoring market growth. The approved gene therapies are Glybera-used to treat Lipoprotein Lipase Deficiency and Strimvelis- treating ADA-Severe Combined Immuno Deficiency. Thus, the factors mentioned above are increasing the demand for the large-scale production of various therapeutics, thereby facilitating the growth of the bioreactors market globally.

South & Central America Bioreactors Market Overview

Brazil has manufacturing plants for a large number of pharmaceutical companies. In addition, many foreign companies often collaborate and partner with Brazilian laboratories and local companies for the development of biotechnology-based medicines. The collaborative efforts are expected to yield the development of novel products in Brazil during the forecast year. 

The majority of research is conducted in universities and other federal state institutions in Brazil. As per the DWIH São Paulo, biotechnology research is one of the first-tier priorities in Brazil. Many studies are being carried out in research centers in Brazil to develop advanced bioreactors for their various applications in the biotechnology sector. For instance, in an article published by MDPI in August 2022, a study was conducted by research departments of universities in Brazil. The study presented a mathematical model that was developed to describe and analyze the bioreactor's dynamic behavior during fermentation, taking into account temperature control via refrigerant fluid flow through the reactor jacket.

Similarly, another study, "Development of a Novel Pilot-Scale Tray Bioreactor for Solid-State Fermentation Aiming at Process Intensification," was carried out by researchers in Brazilian universities in November 2023. These research and development activities are anticipated to boost the bioreactor market in Brazil.

South & Central America Bioreactors Market Revenue and Forecast to 2030 (US$ Million)

Get more information on this report :

South & Central America Bioreactors Market Segmentation  

The South & Central America bioreactors market is segmented based on scale, application, technology, end user, and country. Based on scale, the South & Central America bioreactors market is segmented into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held the largest market share in 2022.

In terms of application, the South & Central America bioreactors market is segmented into microbial application, cell culture application, and others. The cell culture application segment held the largest market share in 2022.

By technology, the South & Central America bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held a larger market share in 2022.

Based on end user, the South & Central America bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held the largest market share in 2022.

Based on country, the South & Central America bioreactors market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bioreactors market share in 2022.

General Electric Co, Merck KGaA, Pall Corp, PBS Biotech Inc, Sartorius AG, Solaris Biotechnology SRL, and Thermo Fisher Scientific Inc are some of the leading players operating in the South & Central America bioreactors market.   

Table of Content

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Bioreactors Market - Key Industry Dynamics

4.1 Bioreactors Market - Key Industry Dynamics

4.2 Market Drivers

4.2.1 Increasing Adoption of Single-Use Bioreactors

4.2.2 Rapid Growth of Pharmaceutical and Biotechnology Industry

4.3 Market Restraints

4.3.1 Stringent Regulatory Framework

4.4 Market Opportunities

4.4.1 Rising Demand for Personalized Medicine

4.5 Future Trends

4.5.1 Technological Advancements in Bioreactors

4.6 Impact of Drivers and Restraints:

5. Bioreactors Market - South & Central America Market Analysis

5.1 Overview

5.2 Bioreactors Market Revenue (US$ Million), 2020 - 2030

6. South & Central America Bioreactors Market Analysis - Scale

6.1 Overview

6.2 Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)

6.3 Lab-Scale Production

6.3.1 Overview

6.3.2 Lab-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)

6.4 Pilot-Scale Production

6.4.1 Overview

6.4.2 Pilot-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)

6.5 Full-Scale Production

6.5.1 Overview

6.5.2 Full-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Bioreactors Market Analysis - Application

7.1 Overview

7.2 Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Microbial Application

7.3.1 Overview

7.3.2 Microbial Application Market, Revenue and Forecast to 2030 (US$ Million)

7.4 Cell Culture Application

7.4.1 Overview

7.4.2 Cell Culture Application Market, Revenue and Forecast to 2030 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Bioreactors Market Analysis - Technology

8.1 Overview

8.2 Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)

8.3 Fed-Batch Bioreactors

8.3.1 Overview

8.3.2 Fed-Batch Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)

8.4 Perfusion Bioreactors

8.4.1 Overview

8.4.2 Perfusion Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Bioreactors Market Analysis - End User

9.1 Overview

9.2 Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)

9.3 Biopharma Manufacturers

9.3.1 Overview

9.3.2 Biopharma Manufacturers Market, Revenue and Forecast to 2030 (US$ Million)

9.4 Research and Development Organizations

9.4.1 Overview

9.4.2 Research and Development Organizations Market, Revenue and Forecast to 2030 (US$ Million)

9.5 Contract Manufacturing Organization

9.5.1 Overview

9.5.2 Contract Manufacturing Organization Market, Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Bioreactors Market - by Country Analysis

10.1 South & Central America: Bioreactors Market

10.1.1 South & Central America Bioreactors Market Revenue and Forecasts and Analysis - By Country

10.1.1.1 Brazil

10.1.1.2 Overview

10.1.1.3 Brazil: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Brazil Bioreactors Market Breakdown by Scale

10.1.1.3.2 Brazil Bioreactors Market Breakdown by Application

10.1.1.3.3 Brazil Bioreactors Market Breakdown by Technology

10.1.1.3.4 Brazil Bioreactors Market Breakdown by End User

10.1.1.4 Argentina

10.1.1.5 Overview

10.1.1.6 Argentina: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Argentina Bioreactors Market Breakdown by Scale

10.1.1.6.2 Argentina Bioreactors Market Breakdown by Application

10.1.1.6.3 Argentina Bioreactors Market Breakdown by Technology

10.1.1.6.4 Argentina Bioreactors Market Breakdown by End User

10.1.1.7 Rest of South & Central America

10.1.1.8 Overview

10.1.1.9 Rest of South & Central America: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.9.1 Rest of South & Central America Bioreactors Market Breakdown by Scale

10.1.1.9.2 Rest of South & Central America Bioreactors Market Breakdown by Application

10.1.1.9.3 Rest of South & Central America Bioreactors Market Breakdown by Technology

10.1.1.9.4 Rest of South & Central America Bioreactors Market Breakdown by End User

11. Bioreactors Market-Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Bioreactors Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 PBS Biotech Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 General Electric Co

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Merck KGaA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Thermo Fisher Scientific Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Sartorius AG

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Pall Corp

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Solaris Biotechnology SRL

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

 

 

List of Tables

Table 1. Bioreactors Market Segmentation

Table 2. Brazil Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Scale

Table 3. Brazil Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Application

Table 4. Brazil Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Technology

Table 5. Brazil Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By End User

Table 6. Argentina Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Scale

Table 7. Argentina Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Application

Table 8. Argentina Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Technology

Table 9. Argentina Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By End User

Table 10. Rest of South & Central America Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Scale

Table 11. Rest of South & Central America Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Application

Table 12. Rest of South & Central America Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Technology

Table 13. Rest of South & Central America Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By End User

Table 14. Recent Inorganic Growth Strategies in the Bioreactors Market

Table 15. Recent Organic Growth Strategies in the Bioreactors Market

Table 16. Glossary of Terms, Bioreactors Market

 

List of Figures

Figure 1. Bioreactors Market Segmentation, By Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. Bioreactors Market Revenue (US$ Million), 2020 - 2030

Figure 4. Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)

Figure 5. Lab-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)

Figure 6. Pilot-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)

Figure 7. Full-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)

Figure 8. Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)

Figure 9. Microbial Application Market Revenue and Forecasts to 2030 (US$ Million)

Figure 10. Cell Culture Application Market Revenue and Forecasts to 2030 (US$ Million)

Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)

Figure 12. Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)

Figure 13. Fed-Batch Bioreactors Market Revenue and Forecasts to 2030 (US$ Million)

Figure 14. Perfusion Bioreactors Market Revenue and Forecasts to 2030 (US$ Million)

Figure 15. Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)

Figure 16. Biopharma Manufacturers Market Revenue and Forecasts to 2030 (US$ Million)

Figure 17. Research and Development Organizations Market Revenue and Forecasts to 2030 (US$ Million)

Figure 18. Contract Manufacturing Organization Market Revenue and Forecasts to 2030 (US$ Million)

Figure 19. South & Central America: Bioreactors Market, By Key Country - Revenue (2022) (US$ Million)

Figure 20. South & Central America Bioreactors Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 21. Brazil Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)

Figure 22. Argentina Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)

Figure 23. Rest of South & Central America Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)

Figure 24. Growth Strategies in the Bioreactors Market

1. General Electric Co

2. Merck KGaA

3. Pall Corp

4. PBS Biotech Inc

5. Sartorius AG

6. Solaris Biotechnology SRL

7. Thermo Fisher Scientific Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America bioreactors market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America bioreactors market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America bioreactors market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2485
Site License
$4550
$3185
Enterprise License
$5550
$3885